Hypersensitivity reactions to iodinated radiocontrast media: Cluster analysis reveals distinct clinical phenotypes.
Clinical phenotype
Cluster analysis
Drug hypersensitivity reaction
Iodinated radiocontrast media
Journal
The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
17
02
2022
revised:
07
07
2022
accepted:
21
07
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
Drug hypersensitivity reaction (DHR) to iodinated radiocontrast media (iRCM) is reported in 1%-3% of injections. Risk assessment of patients with suspicion of DHR to iRCM relies solely on clinical phenotyping and drug allergy workup. Using a novel unsupervised TwoStep cluster analysis, we aimed to identify prototypic patterns within a large cohort of patients evaluated for a potential iRCM DHR. A retrospective study was conducted using data from the Drug Allergy and Hypersensitivity Database of the Allergy Unit, University Hospital of Montpellier, Montpellier, France. All referred patients during February 2001 to December 2019 with suspicion of iRCM DHR with either confirmed positive or confirmed negative skin tests were included in the analysis. A total of 1439 patients were evaluated. The chronology of the index reaction was immediate and nonimmediate in 77.1% and 22.4%, respectively. Cluster analysis categorized the total study population in 5 clusters. Cluster 1 compiled all nonimmediate and cluster 2-5 almost all immediate reactors. Cluster 1 and 2 had recent reactions (<1 y) with mostly known iRCMs and the highest iRCM allergy prevalence (16-17%). In the other clusters, more remote reactions, unknown iRCMs and a lower allergy prevalence (3-8%) was observed. Chronology and semiology of the index reaction were the factors most strongly differentiated among clusters. History of anaphylactic shock and chronology of immediate hypersensitivity reactions were shown to be independent predictors of allergy with adjusted OR (aOR) of 4.68 (95%CI: 3.01-7.27, Unsupervised cluster analysis identified 5 prototypic patterns within patients with a suspected DHR to iRCMs. Well-phenotyped patients cluster together in 2 groups in which the prevalence of allergy is approximately 1 in 6. However, this value decreases for patients with reactions dating back to more than a decade.
Sections du résumé
Background
UNASSIGNED
Drug hypersensitivity reaction (DHR) to iodinated radiocontrast media (iRCM) is reported in 1%-3% of injections. Risk assessment of patients with suspicion of DHR to iRCM relies solely on clinical phenotyping and drug allergy workup. Using a novel unsupervised TwoStep cluster analysis, we aimed to identify prototypic patterns within a large cohort of patients evaluated for a potential iRCM DHR.
Methods
UNASSIGNED
A retrospective study was conducted using data from the Drug Allergy and Hypersensitivity Database of the Allergy Unit, University Hospital of Montpellier, Montpellier, France. All referred patients during February 2001 to December 2019 with suspicion of iRCM DHR with either confirmed positive or confirmed negative skin tests were included in the analysis.
Results
UNASSIGNED
A total of 1439 patients were evaluated. The chronology of the index reaction was immediate and nonimmediate in 77.1% and 22.4%, respectively. Cluster analysis categorized the total study population in 5 clusters. Cluster 1 compiled all nonimmediate and cluster 2-5 almost all immediate reactors. Cluster 1 and 2 had recent reactions (<1 y) with mostly known iRCMs and the highest iRCM allergy prevalence (16-17%). In the other clusters, more remote reactions, unknown iRCMs and a lower allergy prevalence (3-8%) was observed. Chronology and semiology of the index reaction were the factors most strongly differentiated among clusters. History of anaphylactic shock and chronology of immediate hypersensitivity reactions were shown to be independent predictors of allergy with adjusted OR (aOR) of 4.68 (95%CI: 3.01-7.27,
Conclusions
UNASSIGNED
Unsupervised cluster analysis identified 5 prototypic patterns within patients with a suspected DHR to iRCMs. Well-phenotyped patients cluster together in 2 groups in which the prevalence of allergy is approximately 1 in 6. However, this value decreases for patients with reactions dating back to more than a decade.
Identifiants
pubmed: 36092950
doi: 10.1016/j.waojou.2022.100680
pii: S1939-4551(22)00056-4
pmc: PMC9440439
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100680Informations de copyright
© 2022 The Author(s).
Références
Clin Exp Allergy. 2010 Mar;40(3):468-75
pubmed: 20210815
Clin Exp Allergy. 2006 Aug;36(8):1072-7
pubmed: 16911363
PLoS One. 2014 Jun 16;9(6):e100154
pubmed: 24932635
Allergy. 2012 Jul;67(7):929-35
pubmed: 22583135
Allergy. 2017 Jul;72(7):1006-1021
pubmed: 28122115
Allergy. 2021 May;76(5):1325-1339
pubmed: 33170954
Allergy. 2015 Jun;70(6):625-37
pubmed: 25649510
Immunol Allergy Clin North Am. 2014 Aug;34(3):547-64, viii
pubmed: 25017677
J Allergy Clin Immunol. 1996 Mar;97(3):838-50
pubmed: 8613641
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1246-1254
pubmed: 29371073
BMC Med Res Methodol. 2014 Oct 02;14:113
pubmed: 25272975
J Investig Allergol Clin Immunol. 2016;26(3):144-55; quiz 2 p following 155
pubmed: 27326981
Am J Health Syst Pharm. 2021 Apr 22;78(9):781-793
pubmed: 33547463
J Allergy Clin Immunol Pract. 2019 Jan;7(1):61-65
pubmed: 30573421
Int Arch Allergy Immunol. 2011;155(3):297-305
pubmed: 21293150
Eur J Radiol. 2009 Oct;72(1):167-71
pubmed: 18620831
Allergy. 2020 Jun;75(6):1300-1315
pubmed: 31749148
EClinicalMedicine. 2018 Jul 28;1:51-61
pubmed: 31193689
Am J Respir Crit Care Med. 2010 Feb 15;181(4):315-23
pubmed: 19892860
Clin Exp Allergy. 2010 May;40(5):805-10
pubmed: 20337646
J Allergy Clin Immunol. 2016 Feb;137(2):633-635.e4
pubmed: 26428955
Allergy. 1999 Sep;54(9):999-1003
pubmed: 10505466
Am J Respir Crit Care Med. 2013 Sep 1;188(5):550-60
pubmed: 23777340
Asian Pac J Allergy Immunol. 2013 Dec;31(4):299-306
pubmed: 24383973
Allergy. 2009 Feb;64(2):234-41
pubmed: 19178403
Allergy. 2013 Sep;68(9):1203-6
pubmed: 23991759
Br J Radiol. 2017 Feb;90(1070):20160729
pubmed: 27928926
J Allergy Clin Immunol. 2020 Apr;145(4):1082-1123
pubmed: 32001253
Radiology. 2019 Oct;293(1):117-124
pubmed: 31478801
Ann Allergy Asthma Immunol. 2020 Feb;124(2):156-164
pubmed: 31765812